Details about David Blaine Ridley

Access statistics for papers by David Blaine Ridley.

Last updated 2024-01-05. Update your information in the RePEc Author Service.

Short-id: pri238

Working Papers

2023

1. Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine
   NBER Working Papers, National Bureau of Economic Research, Inc
   See also Journal Article Consequences of a shortage and rationing: Evidence from a pediatric vaccine, Journal of Health Economics, Elsevier (2023) (2023)

2017

2. Strategic Interaction Among Governments in the Provision of a Global Public Good
   CEPR Discussion Papers, C.E.P.R. Discussion Papers View citations (6)
   Also in Post-Print, HAL (2017) View citations (6)
   Post-Print, HAL (2017) View citations (6)
   See also Journal Article Strategic interaction among governments in the provision of a global public good, Journal of Public Economics, Elsevier (2017) View citations (6) (2017)

2013

3. Pharmaceutical Followers
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (19)
   See also Journal Article Pharmaceutical followers, International Journal of Industrial Organization, Elsevier (2013) View citations (16) (2013)

2012

4. The Role of Government Reimbursement in Drug Shortages
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (6)
   See also Journal Article The Role of Government Reimbursement in Drug Shortages, American Economic Journal: Economic Policy, American Economic Association (2017) View citations (9) (2017)

2009

5. Herding versus Hotelling: Market Entry with Costly Information
   Levine's Working Paper Archive, David K. Levine View citations (7)
   See also Journal Article Herding versus Hotelling: Market Entry with Costly Information, Journal of Economics & Management Strategy, Wiley Blackwell (2008) View citations (28) (2008)

Journal Articles

2023

1. Consequences of a shortage and rationing: Evidence from a pediatric vaccine
   Journal of Health Economics, 2023, 92, (C)
   See also Working Paper Consequences of a Shortage and Rationing: Evidence from a Pediatric Vaccine, NBER Working Papers (2023) (2023)

2020

2. Does Medicare Reimbursement Drive Up Drug Launch Prices?
   The Review of Economics and Statistics, 2020, 102, (5), 980-993 View citations (3)

2017

3. Regulation of price increases
   International Journal of Industrial Organization, 2017, 50, (C), 186-213 View citations (2)
4. Strategic interaction among governments in the provision of a global public good
   Journal of Public Economics, 2017, 156, (C), 185-199 View citations (6)
   See also Working Paper Strategic Interaction Among Governments in the Provision of a Global Public Good, CEPR Discussion Papers (2017) View citations (6) (2017)
5. The Role of Government Reimbursement in Drug Shortages
   American Economic Journal: Economic Policy, 2017, 9, (2), 348-82 View citations (9)
   See also Working Paper The Role of Government Reimbursement in Drug Shortages, NBER Working Papers (2012) View citations (6) (2012)

2015

6. PAYMENTS, PROMOTION, AND THE PURPLE PILL
   Health Economics, 2015, 24, (1), 86-103 View citations (8)

2013

7. Innovation Incentives under Transferable Fast-Track Regulatory Review
   Journal of Industrial Economics, 2013, 61, (3), 789-816 View citations (2)
8. Pharmaceutical followers
   International Journal of Industrial Organization, 2013, 31, (5), 538-553 View citations (16)
   See also Working Paper Pharmaceutical Followers, NBER Working Papers (2013) View citations (19) (2013)

2009

9. Distance decreases with differentiation: Strategic agglomeration by retailers
   International Journal of Industrial Organization, 2009, 27, (3), 463-473 View citations (39)

2008

10. Herding versus Hotelling: Market Entry with Costly Information
    Journal of Economics & Management Strategy, 2008, 17, (3), 607-631 View citations (28)
    See also Working Paper Herding versus Hotelling: Market Entry with Costly Information, Levine's Working Paper Archive (2009) View citations (7) (2009)

2007

11. Entry and competition in generic biologics
    Managerial and Decision Economics, 2007, 28, (4-5), 439-451 View citations (15)

2006

12. Impact of Medicaid Preferred Drug Lists on Therapeutic Adherence
    PharmacoEconomics, 2006, 24, (3), 65-78 View citations (4)